Csaba Szabo is Professor of Anesthesiology at the University of Texas, Galveston. He obtained his medical degree at the Semmelweis University in Budapest in 1992 and conducted his postdoctoral training in pharmacology with Nobel Laureate Sir John Vane at the William Harvey Research Institute in London between 1992 and 1994. After that, he became Research Director of the Division of Critical Care at Children’s Hospital Medical Center, Cincinnati. In 1999 he became full professor at the University of Medicine and Dentistry of New Jersey, and in 2008 he moved his laboratory to the University of Texas, Galveston, where he is currently based. His original scientific research in the area of nitric oxide/peroxynitrite/poly(ADP-ribose) polymerase in cardiovascular and inflammatory diseases is widely recognized and has opened up several new areas of research and drug development. For the last decade, much of his scientific efforts have focused on the biological effects of hydrogen sulfide, especially in the control of vascular function and cell metabolism. His work received several academic and commercialization awards, including the Texas Star Award and the Novartis Prize. In 2012 he became Elected Fellow of the British Pharmacological Society. With more than 500 full publications, with over 40,000 independent citations received, he is one of the 10 most highly cited pharmacologists in the world today.